Husain, Beate http://orcid.org/0000-0002-3273-1014
Kirchberger, Michael Constantin
Erdmann, Michael
Schüpferling, Sabine
Abolhassani, Amir-Reza
Fröhlich, Waltraud
Berking, Carola
Heinzerling, Lucie http://orcid.org/0000-0003-4587-007X
Funding for this research was provided by:
Förderverein des Tumorzentrums der Universität Erlangen-Nürnberg
SERIO registry (FA 18-005)
e:Med Melautim grant (01ZX1905A)
Universitätsklinikum Erlangen
Article History
Received: 29 September 2020
Accepted: 4 February 2021
First Online: 10 April 2021
Compliance with ethical standards
:
: LH has consulted, served on advisory boards or received honoraria for presentations from BMS, MSD, Sanofi, Pierre Fabre, Roche, Novartis, Amgen, Curevac. ME has served on an advisory board by BMS and received honoraria from Roche. CB has served on advisory boards and/or received honoraria for presentations from Amgen, BMS, Merck, MSD, Novartis, Pierre Fabre, Roche, and Sanofi-Aventis. All remaining authors have declared no conflicts of interest.
: This study was approved by the institutional review board of the medical faculty of the University Erlangen and all procedures performed in studies were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declarations.
: Informed consent was obtained from all individual participants included in the study.
: All authors consented the last version of this manuscript.